StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
7
Publishing Date
2023 - 12 - 21
1
2023 - 05 - 30
1
2022 - 12 - 14
1
2022 - 06 - 03
1
2022 - 04 - 12
1
2021 - 08 - 02
1
2021 - 06 - 07
1
Sector
Health technology
7
Process industries
1
Tags
Agreement
11
Alliances
24
America
28
Antibody
19
Astrazeneca
15
Biotech
28
Breast
11
Breast cancer
13
Cancer
144
Cell
14
Clinical-trials-phase-iii
16
Collaboration
14
Covid-19
8
Diabetes
16
Diagnostic
10
Diagnostics
11
Disease
34
Drug
70
Drug delivery
12
Enhertu
24
Europe
11
Expected
13
Fda
9
Financial
10
Financial results
9
Global
108
Granted
8
Growing
24
Growth
120
Health
9
Her2
27
Her2-
18
Immunotherapy
10
Iot
8
Key
9
License
16
Liver
18
Lung
24
Lung cancer
10
Market
267
Metastatic breast cancer
11
N/a
516
Partnership
8
People
10
Pharma
10
Positive
13
Reach
20
Report
95
Research
73
Respiratory
12
Results
30
Review
11
Set
16
System
9
Technology
10
Therapeutics
71
Therapy
32
Treatment
46
Trial
52
Vaccine
29
Entities
Abbott laboratories
24
Abbvie inc.
37
Adc therapeutics sa
19
Adma biologics inc
17
Agios pharmaceuticals, inc.
11
Allied corp.
7
Alnylam pharmaceuticals, inc.
13
Alvotech lux holdings s.a.s.
7
Amgen inc.
22
Amneal pharmaceuticals, inc.
15
Amphastar pharmaceuticals, inc.
9
Ani pharmaceuticals, inc.
17
Argenx se
10
Arrival
14
Atlanticus holdings corporation
8
Aveo pharmaceuticals, inc.
20
Bausch health companies inc.
8
Beigene, ltd.
25
Biocryst pharmaceuticals, inc.
16
Biogen inc.
20
Blueprint medicines corporation
23
Boston scientific corporation
8
Bristol-myers squibb company
48
Calliditas therapeutics ab
8
Clovis oncology, inc.
19
Cns pharmaceuticals, inc.
11
Eli lilly and company
46
Epizyme, inc.
18
Exelixis, inc.
14
Franchise group, inc.
15
Gilead sciences, inc.
16
Glaxosmithkline plc
10
Guardant health, inc.
12
Halozyme therapeutics, inc.
9
I-mab
8
Illumina, inc.
12
Incyte corporation
41
Jaguar health, inc.
8
Jazz pharmaceuticals plc
8
Johnson & johnson
94
Kamada ltd.
11
Karyopharm therapeutics inc.
31
Lithium corp
11
Medtronic plc
28
Merck & company, inc.
8
Novartis ag
21
Novavax, inc.
10
Orange
21
Perrigo company
21
Pfizer, inc.
31
Reata pharmaceuticals, inc.
9
Regeneron pharmaceuticals, inc.
32
Rigel pharmaceuticals, inc.
11
Sanofi
97
Takeda pharmaceutical company limited
21
Teva pharmaceutical industries ltd
13
Verastem, inc.
10
Vertex pharmaceuticals incorporated
8
Viatris inc.
8
Y-mabs therapeutics, inc.
19
Symbols
ABBV
1
ALB
1
AZN
7
AZNCF
5
BMY
1
GLAXF
2
GNPX
2
GSK
2
IONS
1
LLY
2
NBIX
1
NVS
1
NVSEF
1
PFE
1
SNY
2
SNYNF
2
TEVJF
1
Exchanges
Nasdaq
7
Nyse
2
Crawled Date
2023 - 12 - 22
1
2023 - 05 - 30
1
2022 - 12 - 14
1
2022 - 06 - 03
1
2022 - 04 - 12
1
2021 - 08 - 02
1
2021 - 06 - 07
1
Crawled Time
00:00
1
06:00
1
12:00
1
13:00
1
17:00
1
19:00
2
Source
www.biospace.com
5
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Approval
entities :
Astrazeneca plc
save search
WAINUA™ (eplontersen) granted regulatory approval in the U.S. for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis
Published:
2023-12-21
(Crawled : 00:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
6.31%
|
O:
3.33%
H:
0.0%
C:
-2.93%
IONS
|
$41.85
1.9%
1.86%
630K
|
Health Technology
|
-16.37%
|
O:
1.43%
H:
3.87%
C:
2.77%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
5.78%
|
O:
1.06%
H:
0.18%
C:
-1.06%
granted
approval
treatment
Genprex Receives Safety Review Committee Approval to Advance to Phase 2 Expansion Portion of Acclaim-1 Clinical Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer
Published:
2023-05-30
(Crawled : 13:00)
- biospace.com/
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-4.03%
|
O:
-0.34%
H:
0.21%
C:
-2.03%
GNPX
|
$2.32
7.26%
6.77%
30K
|
Health Technology
|
142.7%
|
O:
1.12%
H:
2.16%
C:
-10.76%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
-3.3%
|
O:
0.44%
H:
0.03%
C:
-1.94%
reqorsa
lung
approval
review
cancer
cell
expansion
trial
Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer
Published:
2022-12-14
(Crawled : 19:00)
- biospace.com/
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
-0.55%
|
O:
-1.61%
H:
1.82%
C:
1.82%
GNPX
|
$2.32
7.26%
6.77%
30K
|
Health Technology
|
88.93%
|
O:
2.34%
H:
5.98%
C:
-0.85%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
0.79%
|
O:
0.76%
H:
1.04%
C:
0.47%
reqorsa
lung
trial
approval
review
cancer
Global Panic Disorders Market Insights | Size | Shares | Trends | Growth | Industry Analysis [2020-2030] Panic disorders, also known as anxiety disorder deals with recurrent and unexpected panic attacks. PET-CT Scanner Devices Market: Competitive Landscape Analysis With Forecast by 2031 Wilmington, Delaware: According to the report, the global PET-CT scanner devices market was valued over US$ 200 Mn in 2020 and is projected to expand at a CAGR of ~3% from 2021 to 2031. Portal Hypertension Market Insights | Current Trends | Growth Opportunity | Global Industry Analysis [2020-2030] At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. Spatial Genomics & Transcriptomics Market to Experience Significant Growth by 2027 Wilmington, Delaware: The spatial genomics & transcriptomics market is prognosticated to bring profitable growth during the assessment period of 2019-2027. Teleradiology Services Market to Make Great Impact in Near Future by 2031 Wilmington, Delaware: According to the report, the global teleradiology services market was valued over US$ 6.4 Bn in 2020. Anti-depressants Drugs and Therapies Market to Witness a Pronounce Growth by 2025 Wilmington, Delaware: Anti-depressants medications lower the symptoms of depression, dysthymia, chronic depression, and anxiety disorders. B-Cell Non-Hodgkin’s Lymphoma (NHL) Market to Offer Ample Growth Opportunities by 2027 Wilmington, Delaware: Non-Hodgkin’s lymphoma is a group of heterogeneous proliferative malignancies. Heightening Healthcare Spending Opening Growth Avenues for Collateral Ligament Stabilizer System Market, Reaching US$ 3.5 Billion in 2032: Fact.MR Study Fact.MR – A Market Research and Competitive Intelligence Provider: The global collateral ligament stabilizer system market is expected to reach US$ 3.5 Billion by the end of the 2022-2032 forecast period, growing at a CAGR of 6.1%, concludes a recently published report by Fact.MR. Breast Cancer Liquid Biopsy Market Trends, Growth, Analysis and Future Scope, 2026 Wilmington, Delaware: A biopsy is a tissue or cell sample taken from any part of the patient’s body and examined in the lab for the detection of cancer. Cerebral Palsy Market Size, Shares, Trends and Growth | Global Industry Analysis [2020-2030] The global cerebral palsy market is picking up steam due to increasing awareness about the condition amongst parents. Continuous Glucose Monitoring Market: Competitive Research and Precise Outlook 2021 to 2028 Wilmington, Delaware: The global continuous glucose monitoring market depicts the presence of a large competitive vendor landscape, says Transparency Market Research on the basis of a newly research report. Crow’s Feet Market Key Trends and Opportunity Analysis up to 2026 Albany NY, United States: The demand within the global crow’s feet market has been escalating on account of vital advancements in the field of dermatology in recent times. HIV Associated Lipodystrophy Syndrome Market Insights | Global Industry Analysis [2020-2030] HIV-associated lipodystrophy is a syndrome that are found in human immune-deficiency virus -infected patients who are being administered with active antiretroviral medications for the treatment of HIV infection. Global Mail Service Pharmacy Market | Size | Shares | Trends | Growth | Forecast [2020-2030]
Published:
2022-06-03
(Crawled : 06:00)
- biospace.com/
GLAXF
|
News
|
$20.305
-14.18%
630
|
Health Technology
|
-23.94%
|
O:
-1.55%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-13.16%
|
O:
-0.94%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
7.78%
|
O:
-0.4%
H:
4.05%
C:
-1.35%
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-49.79%
|
O:
0.57%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-6.11%
|
O:
-0.14%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
135.91%
|
O:
-2.25%
H:
0.0%
C:
0.0%
BMY
|
$48.99
-0.31%
0.0%
9.1M
|
Health Technology
|
-34.89%
|
O:
-1.4%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-13.75%
|
O:
-0.09%
H:
0.0%
C:
0.0%
NBIX
|
News
M
|
$140.11
4.83%
4.6%
1.6M
|
Health Technology
|
45.16%
|
O:
2.29%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
5.47%
|
O:
-0.56%
H:
0.82%
C:
-0.64%
lipodystrophy
treatment
research
system
active
services
report
service
growing
hiv
profitable
hypertension
genomics
expected
virus
approval
cancer
growth
group
market
breast cancer
infections
Global Pharmaceutical API Manufacturing Market Report 2022-2030: Stringent Regulations for Approval of Pharmaceutical Drugs Restraining Growth
Published:
2022-04-12
(Crawled : 17:00)
- prnewswire.com
AZNCF
|
News
|
$138.73
-4.19%
3.7K
|
Health Technology
|
0.57%
|
O:
-0.86%
H:
1.21%
C:
1.21%
NVSEF
|
News
|
$95.11
6.88%
490
|
Health Technology
|
24.93%
|
O:
0.16%
H:
0.22%
C:
0.22%
NVS
|
News
|
$97.28
2.27%
0.31%
3.7M
|
Health Technology
|
1.09%
|
O:
-0.48%
H:
0.09%
C:
-0.68%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
-13.55%
|
O:
-0.36%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
|
136.71%
|
O:
-0.77%
H:
0.99%
C:
0.49%
ALB
|
News
|
$114.21
1.71%
0.0%
1.7M
|
Process Industries
|
-45.49%
|
O:
1.31%
H:
2.06%
C:
-1.76%
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
|
-1.14%
|
O:
-0.31%
H:
0.74%
C:
-1.18%
SNY
|
News
|
$47.69
1.15%
1.13%
1.7M
|
Health Technology
|
-20.05%
|
O:
-3.25%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
-0.71%
|
O:
-2.32%
H:
0.43%
C:
-0.55%
report
approval
growth
market
drug
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca's anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)
Published:
2021-08-02
(Crawled : 12:00)
- biospace.com/
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
22.07%
|
O:
-0.7%
H:
0.86%
C:
0.58%
fda
fda approval
research
approval
lupus
Alexion Announces FDA Approval of ULTOMIRIS® (ravulizumab-cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Published:
2021-06-07
(Crawled : 19:00)
- biospace.com/
AZN
|
News
|
$70.85
1.03%
1.02%
5.6M
|
Health Technology
|
23.47%
|
O:
-0.32%
H:
0.6%
C:
-0.39%
fda
fda approval
children
approval
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.